Оценка реактивности лейкоцитов при аденокарциномах желудочно-кишечного тракта
Диссертация
При аденокарциномах желудка и толстой кишки активируются функции мононуклеаров и гранулоцитов, о чем свидетельствует повышенное содержание в сыворотке крови больных аденокарциномами желудка IL-6 и IL-1 Ra, а у больных аденокарциномами толстой кишки, кроме повышенного содержания вышеуказанных цитокинов, и IL-8. При раке желудка содержание провоспалительного цитокина 1L-6 находится в прямой… Читать ещё >
Список литературы
- Абелев, Г. И. Дифференцировочные антигены в опухолях -зависимость от механизмов канцерогенеза и прогрессии (гипотеза) / Г. И. Абелев // Молекулярная биология. — 2003. — Т. 37. — № 1. — С. 4−11.
- Абелев, Г. И. На пути к пониманию природы рака / Г. И. Абелев, Т.Л. Эрайзер//Биохимия. 2008. — Т. 73.-№ 5.-С. 605−618.
- Автандилов, Г. Г. Медицинская морфометрия / Автандилов Г. Г. -М.: Медицина, 1990. 382 с.
- Акопов, А.Л. Опухолевая инвазия сосудов при отсутствии метастазов в регионарные лимфатические узлы у больных местнораспространенным немелкоклеточным раком легкого / А. Л. Акопов, И. В. Двораковская // Вопросы онкологии. 2004. — Т. 50. — № 4. — С. 417−420.
- Аутеншлюс, А.И. Реакция лимфоцитов и гуморальный иммунный ответ на опухолеассоциированные антигены у онкологических больных / А. И. Аутеншлюс, Г. Г. Иванова, В. М. Столярова и др. // Бюлл. СО РАМН. 1999. -№ 3−4.-С. 60−63.
- Аутеншлюс, А.И. Ответ лимфоцитов больных фиброаденоматозом и раком молочной железы на опухолеассоциированные антигены in vitro / А. И. Аутеншлюс, Г. Г. Иванова, С. В. Сидоров и др. // Иммунология. 2003. — № 1. -С. 26−28.
- Аутеншлюс, А.И. Содержание цитокинов и антител к ФНО-а у больных раком молочной железы и фиброаденоматозом / А. И. Аутеншлюс, Г. Г. Иванова, С. В. Сидоров и др. // Иммунология. 2003. — № 3. — С. 140−142.
- Аутеншлюс, А.И. Иммуногенетический анализ реакции лимфоцитов на опухолеассоциированные антигены у больных раком молочной железы ифиброаденоматозом / А. И. Аутеншлюс, В. И. Коненков, И. Ю. Короткова и др. // Бюлл. СО РАМН. 2004. — № 4. — С. 67−74.
- И. Аутеншлюс, А. И. Содержание цитокинов IL-ip, TNF-a и уровни антител к TNF-a у больных с онкологическими и воспалительными заболеваниями / А. И. Аутеншлюс, А. Н. Шкунов, Г. Г. Иванова и др. // Цитокины и воспаление. 2005. — Т. 4. — № 3. — С. 11−15.
- Барышников, А.Ю. Взаимоотношение опухоли и иммунной системы организма / А. Ю. Барышников // Практическая онкология. 2003. -Т. 4. — № 3. — С. 127−130.
- Бережной, А.Е. Молекулярные механизмы взаимодействия опухоли и иммунной системы / А. Е. Бережной, Н. В. Гнучев, Г. П. Георгиев и др. // Вопросы онкологии. 2008. — Т. 54. — № 6. — С. 669−683.
- Галактионов, В.Г. Иммунология : учебник для студентов вузов / В. Г. Галактионов. — 3-е изд., перераб. и доп. — М.: Академия, 2004. 528 с.
- Гланц, С. Медико-биологическая статистика / С. Гланц — пер. Ю. А. Данилова — под ред. Н. Е. Бузикашвили, Д. В. Самойлова М.: Практика, 1999.-459 с.
- Гранов, A.M. Канцерогенез и иммунобиология опухоли. Функциональные и клинические аспекты / A.M. Гранов, О. Е. Молчанов // Вопросы онкологии. 2008. — Т. 54. — № 4. — С. 401−409.
- Громова, А.Ю. Полиморфизм генов семейства IL-1 человека / А. Ю. Громова, А. С. Симбирцев // Цитокины и воспаление. 2005. — Т. 4. — № 2. -С. 3−12.
- Давыдов, М.И. Статистика злокачественных новообразований в России и странах СНГ в 2007 г. / М. И. Давыдов, Е. М. Аксель // Вестник Российского научного центра им. Н. Н. Блохина РАМН. 2008. — Т. 20. — № 3 (при л. 1).
- Драницына, С.М. Эндогенный фактор дифференцировки клеток линии HL-60 обладает нуклеазной активностью / С. М. Драницына, И. А. Костанян, С. Г. Андреева и др. // Биоорганическая химия. 2000. — Т. 26. — № 5.-С. 340−351.
- Ермолович, Е.Ю. Моделирование тактивином продукции интерлейкина-ip и фактора некроза опухоли, а у больных остеомиелитом / Е. Ю. Ермолович, B.C. Кожевников, B.C. Цинкер, В. П. Лозовой // Иммунология. 1996. — № 2. — С. 33−35.
- Кадагидзе, З.Г. Цитокины / З. Г. Кадагидзе // Практическая онкология.-2003.-Т. 4. -№ 3. С. 131−139.
- Кадагидзе, З.Г. Регуляторные Т-клетки и их роль в противоопухолевом иммунном ответе / З. Г. Кадагидзе, А. И. Черткова, Е. Г. Славина // Вопросы онкологии. 2009. — Т. 55. — № 3. — С. 269−277.
- Ковязин, В.А. Проапоптотический фактор HLDF в нормальном, гиперпластическом и опухолевом эндометрии / В. А. Ковязин, Е. Е. Щелокова, И. А. Костанян и др. // Архив патологии. 2007. — Т. 69. — № 3. — С.23−26.
- Костанян, И.А. Биологически активный фрагмент фактора дифференцировки клеток линии HL-60. Идентификация и свойства / И. А. Костанян, М. В. Астапова, Е. В. Наволоцкая и др. // Биоорганическая химия. -2000. Т. 26. — № 7. — С. 505−511.
- Кузнецов, В.П. Интерфероны в каскаде цитокинов: исторический и современный аспекты / В. П. Кузнецов // Антибиотики и химиотерапия. -1998.-№ 5.-С. 28−40.
- Леонова, Т.Я. Контроль качества лабораторных исследований: методические рекомендации для врачей-лаборантов / Т. Я. Леонова, Е. Г. Степанова. — Новосибирск, 1993. 23 с.
- Мальцева, В.Н. Наблюдение в динамике модификации функциональной активности периферических нейтрофилов и ее регуляции при росте опухоли in vivo / В. Н. Мальцева, Н. В. Авхачева, Б. Ф. Санталов, В.Г. Сафронова//Цитология. 2006. — Т. 48.-№ 12.-С. 1000−1008.
- Маянский, А.Н. Реактивность и медиаторные функции интестинальных эпителиоцитов в системе мукозального гомеостаза / А. Н. Маянский, И. В. Маянская // Иммунология. 2004. — Т. 25. — № 3. — С 185 192.
- Олейник, Е.К. Динамика экспрессии маркеров активации лимфоцитов больных с опухолями желудочно-кишечного тракта на разных стадиях заболевания / Е. К. Олейник, М. И. Шибаев, В. М. Олейник // Вопросы онкологии. 2005. — Т. 51. — № 5. — С. 571−574.
- Останин, А.А. Сравнительная оценка уровня 17 цитокинов в сыворотке и цельной крови здоровых доноров методом проточной флюориметрии / А. А. Останин, Е. Р. Черных // Цитокины и воспаление. -2005. Т. 4. — № 2. — С. 25−32.
- Пащенков, М.В. Физиология клеток врожденной иммунной системы: дендритные клетки / М. В. Пащенков, Б. В. Пинегин // Иммунология. 2006. — Т. 27. — № 6. — С. 368−378.
- Реброва, О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA / О. Ю. Реброва. -М.: МедиаСфера, 2002. 312 с.
- Савина, Н.П. Антигомеостатическая роль иммунной системы у онкологических больных / Н. П. Савина // Российский онкологический журнал. 2009. — № 2. — С. 53−56.
- Селихова, Ю.Б. Параметры иммунитета у больных раком молочной железы после лучевой терапии и хирургического лечения / Ю. Б. Селихова, И. Б. Останина, Н. М. Старостина и др. // Медицинская иммунология. 2007. -Т. 9.-№ 4−5.-С. 419−428.
- Телетаева, Г. М. Цитокины и противоопухолевый иммунитет / Г. М. Телетаева // Практическая онкология. 2007. — Т. 8. — № 4. — С. 211−218.
- Фрейдлин, И.С. Регуляторные Т-клетки: происхождение и функции / И. С. Фрейдлин // Медицинская иммунология. 2005. — Т. 7. — № 4. — С. 347 354.
- Чуров, А.В. TGFpl и регуляторные Т-клетки в формировании иммунной супрессии у онкологических больных / А. В. Чуров, Е. К. Олейник, В. М. Олейник // Цитокины и воспаление. 2009. — Т. 8. — №> 2. — С. 27−30.
- Ярилин, А.А. Естественные регуляторные Т-клетки и фактор Foxp3 / А. А. Ярилин, А. Д. Донецкова // Иммунология. 2006. — Т. 27. — № 3. — С. 176−188.
- Adam, J.K. Immune responses in cancer / J.K. Adam, B. Odhav, K.D. Bhoola// Pharmacol. Ther. 2003. -Vol. 99. -№ l.-P. 113−132.
- Adler, A.J. Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones / A.J. Adler // Curr. Cancer Drug Targets. 2007. — Vol. 7.-№ l.-P. 3−14.
- Adler, H.S. Tolerogenic dendritic cells in health and disease: friend and foe! / H.S. Adler, K. Steinbrink // Eur. J. Dermatol. 2007. — Vol. 17. — № 6. — P. 476−491.
- Ajioka, Y. Significance of MUC1 and MUC2 mucin expression in colorectal cancer / Y. Ajioka, L.J. Allison, J.R. Jass // J. Clin. Pathol. 1996. -Vol. 49. — № 7. — P. 560−564.
- Amin, M.A. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways / M.A. Amin, P.J. Mansfield, A. Pakozdi et al. // Arthritis Rheum. 2007. — Vol. 56. — № 6. — P. 1787−1797.
- Arend, W.P. Biological role of interleukin 1 receptor antagonist isoforms / W.P. Arend, C.J. Guthridge // Ann. Rheum. Dis. 2000. — Vol. 59. -Suppl. l.-P. i60-i64.
- Ashizawa, T. Study of interleukin-6 in the spread of colorectal cancer: the diagnostic significance of IL-6 / T. Ashizawa, R. Okada, Y. Suzuki et al. // Acta Med. Okayama. 2006. — Vol. 60. — № 6. — P. 325−330.
- Axelrod, R. Evolution of cooperation among tumor cells / R. Axelrod, D.E. Axelrod, K.J. Pienta // Proc. Natl. Acad. Sci. USA.- 2006. Vol. 103. — № 36.-P. 13 474−13 479.
- Bachmann, M.F. Interleukin 2: from immunostimulation to immunoregulation and back again / M.F. Bachmann, A. Oxenius // EMBO Rep. -2007.-Vol. 8. -№ 12.-P. 1142−1148.
- Bakhiet, M. Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis / M. Bakhiet, M. Mustafa, J. Zhu et al. // Clin. Exp. Immunol. 1998. — Vol. 114. — № 3. — P. 398−402.
- Bakker, A.B. Melanocyte lineage-specific antigen gplOO is recognized by melanoma-derived tumor-infiltrating lymphocytes / A.B. Bakker, M.W. Schreurs, A.J. de Boer et al. // J. Exp. Med. 1994. — Vol. 179. — № 3. — P. 10 051 009.
- Barksby, H.E. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders / H.E. Barksby, S.R. Lea, P.M. Preshaw, J.J. Taylor // Clin. Exp. Immunol. 2007. — Vol. 149. — № 2. — P. 217 225.
- Becker, C. IL-6 signaling promotes tumor growth in colorectal cancer / C. Becker, M.C. Fantini, S. Wirtz et al. // Cell Cycle. 2005. — Vol. 4. — № 2. — P. 217−220.
- Benchetrit, F. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism / F. Benchetrit, A. Ciree, V. Vives et al. // Blood. -2002. Vol. 99. -№ 6. — P. 2114−2121.
- Bergers, G. Modes of resistance to anti-angiogenic therapy / G. Bergers, D. Hanahan // Nat. Rev. Cancer. 2008. — Vol. 8. — № 8. — P. 592−603.
- Berzofsky, J.A. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis / J.A. Berzofsky, M. Terabe // J. Immunol. 2008. -Vol. 180. -№ 6. -P. 3627−3635.
- Bhardwaj, N. Harnessing the immune system to treat cancer / N. Bhardwaj // J. Clin. Invest. 2007. — Vol. 117. — № 5. — P. 1130−1136.
- Bindra, R.S. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis / R.S. Bindra, P.M. Glazer // Mutat. Res. 2005. — Vol. 569. — № 1−2. — P. 75−85.. .
- Bodger, K. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion / K. Bodger, J.I. Wyatt, R.V. Heatley // Gut. 1997. — Vol. 40. — № 6. -P. 739−744.
- Brar, S.S. An NAD (P)H oxidase regulates growth and transcription in melanoma cells / S.S. Brar, T.P. Kennedy, A.B. Sturrock et al. // Am. J. Physiol. Cell Physiol. 2002. — Vol. 282. — № 6. — P. C1212-C1224.
- Brat, D.J. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis / D.J. Brat, A.C. Bellail, E.G. Van Meir // Neuro-oncol. 2005. — Vol. 7. — № 2. — P. 122−133.
- Brichard, V. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas / V. Brichard, A. Van Pel, T. Wolfel et al. //J. Exp. Med. 1993. — Vol. 178. -№ 2. — P. 489−495.
- Bru, A. Pinning of tumoral growth by enhancement of the immune response / A. Bru, S. Albertos, J.A. Lopez Garcia-Asenjo, I. Bru // Phys. Rev. Lett. -2004.-Vol. 92.-№ 23.-P. 238 101−238 104.
- Burchill, M.A. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis / M.A. Burchill, J. Yang, K.B. Vang, M.A. Farrar // Immunol. Lett.-2007.-Vol. 114.-№ l.-P. 1−8.
- Butcher, D.T. A tense situation: forcing tumour progression / D.T. Butcher, T. Alliston, V.M. Weaver // Nat. Rev. Cancer. 2009. — Vol. 9. — № 2. -P. 108−122.
- Bykova, A. The concept of an immune mechanism of chemical homeostasis and its importance in biology and medicine / A. Bykova, E. Baker // Nat. Immun. 1998. — Vol. 16. -№ 5−6. — P. 198−206.
- Campbell, L.L. Breast tumor heterogeneity: cancer stem cells or clonal evolution? / L.L. Campbell, K. Polyak // Cell Cycle. 2007. — Vol. 6. — № 19. — P. 2332−2338.
- Campoli, M. HLA class I antigen loss, tumor immune escape and immune selection / M. Campoli, C.C. Chang, S. Fen-one // Vaccine. 2002. — Vol. 20. — Suppl. 4. — P. A40-A45.
- Campoli, M. Mechanisms of tumor evasion / M. Campoli, S. Ferrone, A.H. Zea et al. // Cancer Treat. Res. 2005. — Vol. 123. — P. 61−88.
- Caponetti, R. Changes in tumor markers CEA, Ca 19−9 and Ca 125 in monitoring of response to chemotherapy in elderly patients with advanced gastric cancer / R. Caponetti, T. Caponetti, P. Vici // Clin. Ter. 2002. — Vol. 153. — № 6. -P. 373−375.
- Carmi, Y. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis / Y. Carmi, E. Voronov, S. Dotan et al. // J. Immunol. 2009. — Vol. 183. — № 7. — P. 4705−4714.
- Carter, R.H. В cells in health and disease / R.H. Carter // Mayo Clin. Proc. 2006. — Vol. 81. — № 3. — P. 377−384.
- Casiano, C.A. Tumor-associated antigen arrays for the serological diagnosis of cancer / C.A. Casiano, M. Mediavilla-Varela, E.M. Tan // Mol. Cell. Proteomics. 2006. — Vol. 5. — № 10. — P. 1745−1759.
- Chan, C.W. The 'kiss of death' by dendritic cells to cancer cells / C.W. Chan, F. Housseau // Cell Death. Differ. 2008. — Vol. 15. — № 1. — P. 58−69.
- Chang, C.Y. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Thl response in a mouse hepatic cancer model / C.Y. Chang, J. Lee, E.Y. Kim et al. // BMC Cancer. 2007. — Vol. 7. — P. 87.
- Chen, G.Y. The innate immune receptor Nodi protects the intestine from inflammation-induced tumorigenesis / G.Y. Chen, M.H. Shaw, G. Redondo, G. Nunez // Cancer Res. 2008. — Vol. 68. — № 24. — P. 10 060−10 067.
- Cheng, P. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein / P. Cheng, C.A. Corzo, N. Luetteke et al. // J. Exp. Med. 2008. — Vol. 205. — № 10. -P. 2235−2249.
- Chung, Y.C. Significance of inflammatory cytokines in the progression of colorectal cancer / Y.C. Chung, Y.F. Chang // Hepatogastroenterology. 2003. -Vol. 50.-№ 54.-P. 1910−1913.
- Clarke, S.L. CD4+CD25+FOXP3+ regulatory T cells suppress antitumor immune responses in patients with colorectal cancer / S.L. Clarke, G.J. Betts, A. Plant et al. // PLoS One. 2006. — Vol. 1. — P. 129.
- Corthay, A. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells / A. Corthay, K.U. Lundin, K.B. Lorvik et al. // Cancer Res. 2009. — Vol. 69. — № 14. — P. 59 015 907.
- Costantino, C.M. Human regulatory T cells and autoimmunity / C.M. Costantino, C.M. Baecher-Allan, D.A. Hafler // Eur. J. Immunol. 2008. — Vol. 38.-№ 4.-P. 921−924.
- Crimeen-Irwin, B. Failure of immune homeostasis the consequences of under and over reactivity / B. Crimeen-Irwin, K. Scalzo, S. Gloster et al. // Curr. Drug Targets Immune Endocr. Metabol. Disord. — 2005. — Vol. 5. — № 4. — P. 413 422.
- Dhodapkar, M.V. Interactions of tumor cells with dendritic cells: balancing immunity and tolerance / M.V. Dhodapkar, K.M. Dhodapkar, A.K. Palucka // Cell Death Differ. 2008. — Vol. 15. — № 1. — P. 39−50.
- Dinarello, C.A. Targeting interleukin 18 with interleukin 18 binding protein / C.A. Dinarello // Ann. Rheum. Dis. 2000. — Vol. 59. — Suppl. 1. — P. il7-i20.
- Dinarello, C.A. Novel targets for interleukin 18 binding protein / C.A. Dinarello // Ann. Rheum. Dis. 2001. — Vol. 60. — Suppl. 3. — P. iiilS- iii24.
- Dinarello, C.A. Blocking IL-1 in systemic inflammation / C.A. Dinarello // J. Exp. Med. 2005. — Vol. 201. — № 9. — P. 1355−1359.
- Dudler, J. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection / J. Dudler, E. Simeoni, S. Fleury et al. // Transpl. Int. -2007. Vol. 20. — № 5. — P. 460−466.
- Dukovski, D. Structural and functional studies on the stalk of the transferrin receptor / D. Dukovski, Z. Li, D.F. Kelly et al. // Biochem. Biophys. Res. Commun. 2009. — Vol. 381. -№ 4. — P. 712−716.
- Dummer, R. Long-term pegylated interferon-alpha and its potential in the treatment of melanoma / R. Dummer, J. Mangana // Biologies. 2009. — Vol. 3.-P. 169−182.
- Duncan, T.J. Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer / T.J. Duncan, P. Rolland, S. Deen et al. // Clin. Cancer Res.-2007.-Vol. 13. -№ 14.-P. 4139−4145.
- Duncan, T.J. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer / T.J. Duncan, N.F. Watson, A.H. Al-Attar et al. // World J. Surg. Oncol. 2007. — Vol. 5. — P. 31.
- Elaraj, D.M. The role of interleukin 1 in growth and metastasis of human cancer xenografts / D.M. Elaraj, D.M. Weinreich, S. Varghese et al. // Clin. Cancer Res. 2006. — Vol. 12. — № 4. — P. 1088−1096.
- Erdogan, B. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients / B. Erdogan, E. Uzaslan, F. Budak et al. // Tuberk. Toraks. 2005. — Vol. 53. — № 2. — P. 127−131.
- Erler, J.T. Three-dimensional context regulation of metastasis / J.T. Erler, V.M. Weaver // Clin. Exp. Metastasis. 2009. — Vol. 26. — № 1. — P. 35−49.
- Esteban, F. MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up / F. Esteban, M. Redondo, M. Delgado et al. // Br. J. Cancer. 1996. — Vol. 74. — № 11. — 1801−1804.
- Fazio, M. Leukocyte adherence inhibition test: cell-mediated reactivity to tumor antigens in colorectal and lung tumor long survivors / M. Fazio, F. Calabrese, M. Camandona et al. // Tumori. 1991. — Vol. 77. — № 6. — P. 500−505.
- Feghali, C.A. Cytokines in acute and chronic inflammation / C.A. Feghali, T.M. Wright // Front. Biosci. 1997. — Vol. 2. — P. dl2- d26.
- Ferrero, E. The metamorphosis of a molecule: from soluble enzyme to the leukocyte receptor CD38 / E. Ferrero, F. Malavasi // J. Leukoc. Biol. 1999. -Vol. 65.-№ 2.-P. 151−161.
- Ferrone, S. Tumor microenvironment and immune escape / S. Ferrone, T.L. Whiteside // Surg. Oncol. Clin. N. Am. 2007. — Vol. 16. — № 4. — P. 755 774.
- Foran, J.M. Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis / J.M. Foran, A.J. Norton, I.N. Micallef et al. // Br. J. Haematol. 2001. — Vol. 114. — № 4. — P. 881−883.
- Francipane, M.G. Crucial role of interleukin-4 in the survival of colon cancer stem cells / M.G. Francipane, M.P. Alea, Y. Lombardo et al. // Cancer Res. -2008.-Vol. 68.-№ 11.- P. 4022−4025.
- Frankel, B. Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion / B. Frankel, S.L. Longo, G.W. Canute // J. Neurooncol. 2000. — Vol. 48. — № 1. — P. 21−26.
- Frey, A.B. Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response / A.B. Frey, N. Monu // J. Leukoc. Biol. -2006. Vol. 79. — № 4. — P. 652−662.
- Fridlender, Z.G. Polarization of tumor-associated neutrophil phenotype by TGF-beta: «Nl» versus «N2» TAN / Z.G. Fridlender, J. Sun, S. Kim et al. // Cancer Cell. 2009. — Vol. 16.-№ 3.-P. 183−194.
- Fu, B.M. Tolerogenic semimature dendritic cells induce effector T-cell hyporesponsiveness by the activation of antigen-specific CD4+ CD25+ T-regulatory cells / B.M. Fu, X.S. He, S. Yu et al. // Exp. Clin. Transplant. 2009. -Vol. 7. -№ 3. — P. 149−156.
- Fukumura, D. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization / D. Fukumura, R.K. Jain // Microvasc. Res. 2007. — Vol. 74. — № 2−3. — P. 72−84.
- Gallimore, A. Regulation of tumour immunity by CD25+ T cells / A. Gallimore, S. Sakaguchi // Immunology. 2002. — Vol. 107. — № 1. — P. 5−9.
- Gao, F. Dysfunction of murine dendritic cells induced by incubation with tumor cells / F. Gao, X. Hui, X. He et al. // Cell Mol. Immunol. 2008. -Vol. 5. — № 2. — P. 133−140.
- Garcia-Tunon, I. Influence of IFN-gamma and its receptors in human breast cancer / I. Garcia-Tunon, M. Ricote, A.A. Ruiz et al. // BMC Cancer. -2007.-Vol. 7.-P. 158.
- Garrett, P.E. Clinical utility of oncofetal proteins and hormones as tumor markers / P.E. Garrett, S.R. Kurtz // Med. Clin. North. Am. 1986. — Vol. 70.-№ 6. -P. 1295−1306.
- Gatenby, R.A. An evolutionary model of carcinogenesis / R.A. Gatenby, T.L. Vincent // Cancer Res. 2003. — Vol. 63. — № 19. — P. 6212−6220.
- Gavin, M. Control of immune homeostasis by naturally arising regulatory CD4+ T cells / M. Gavin, A. Rudensky // Curr. Opin. Immunol. 2003. -Vol. 15.-№ 6.-P. 690−696.
- Gerhardt, A. Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer / A. Gerhardt, D. Usener, M. Keese et al. // Cancer Lett. 2004. — Vol. 208. — № 2. — P. 197−206.
- Gerlini, G. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions / G. Gerlini, A. Tun-Kyi, C. Dudli et al. // Am. J. Pathol. 2004. — Vol. 165. — № 6. — P. 1853−1863.
- Germano, G. Cytokines as a key component of cancer-related inflammation / G. Germano, P. Allavena, A. Mantovani // Cytokine. 2008. — Vol. 43. -№ 3. — P. 374−379.
- Gilli, F. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs / F. Gilli, A. Bertolotto, A. Sala et al. // Brain. 2004. — Vol. 127. — № 2. — P. 259−268.
- Gougerot-Pocidalo, M.A. Regulation of human neutrophil oxidative burst by pro- and anti-inflammatory cytokines / M.A. Gougerot-Pocidalo, J. el Benna, C. Elbim et al. // J. Soc. Biol. 2002. — Vol. 196. — № 1. — P. 37−46.
- Goyos, A. Tumorigenesis and anti-tumor immune responses in Xenopus / A. Goyos, J. Robert // Front. Biosci. 2009. — Vol. 14. — P. 167−176.
- Grutz, G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression / G. Grutz // J. Leukoc. Biol. 2005. — Vol. 77. -№ 1.-P. 3−15.
- Haas, M. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia / M. Haas, A. Dimmler, W. Hohenberger et al. // BMC Gastroenterology. 2009. — Vol. 9. — P. 65.
- Halin, S. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model / S. Halin, S.H. Rudolfsson, N. Van Rooijen, A. Bergh // Neoplasia. 2009. — Vol. 11. — № 2. — P. 177−186.
- Hammel, P. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer / P. Hammel, B. Boissier, M-T. Chaumette et al. // Gut. 1997. — Vol. 40. — № 3. — P. 356−361.
- Hansen, M.B. Transfusion-related inhibition of cytokines (TRICK). Experimental transfer of neutralizing autoantibodies to interleukin-6 by plasma transfusions / M.B. Hansen, P. Galle, M. Salomo et al. // Vox Sang. 2007. — Vol. 92. -№ 3. p. 213−223.
- He, Z. Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury / Z. He, L. Lu, C. Altmann et al. // Am. J. Physiol. Renal Physiol. -2008. Vol. 295. -№ 5. — P. F1414-F1421.
- Hertzog, P.J. Oncofetal expression of the human intestinal mucin glycoprotein antigens in gastrointestinal epithelium defined by monoclonal antibodies / P.J. Hertzog, H.C. Robinson, J. Ma et al. // Int. J. Cancer. 1991. -Vol. 48. -№ 3. — P. 355−363.
- Hoffmann, P.R. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo / P.R. Hoffmann, J.A. Kench, A. Vondracek et al. // J. Immunol. 2005. — Vol. 174. — № 3. — P. 1393−1404.
- Holling, T.M. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men / T.M. Holling, E. Schooten, P.J. van Den Elsen // Hum. Immunol. 2004. — Vol. 65. — № 4. — P. 282−290.
- Holtan, S.G. Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents / S.G. Holtan, D.J. Creedon, P. Haluska, S.N. Markovic // Mayo Clin. Proc. 2009. — Vol. 84. -№ 11.-P. 985−1000.
- Hong, D.S. Interleukin-6 and its receptor in cancer: implications for Translational Therapeutics / D.S. Hong, L.S. Angelo, R. Kurzrock // Cancer. -2007.-Vol. 110. -№ 9. — P. 1911−1928.
- Ни, M. Overlapping gene expression in fetal mouse intestine development and human colorectal cancer / M. Hu, R.A. Shivdasani // Cancer Res. -2005.-Vol. 65. -№ 19.-P. 8715−8722.
- Huang, L.E. Hypoxia-induced genetic instability a calculated mechanism underlying tumor progression / L.E. Huang, R.S. Bindra, P.M. Glazer, A.L. Harris // J. Mol. Med. — 2007. — Vol. 85. — № 2. — P. 139−148.
- Huang, S.C. Extracellular matrix proteases cytokine regulation role in cancer and pregnancy / S.C. Huang, B.C. Sheu, W.C. Chang et al. // Front. Biosci.-2009.-Vol. 14.-P. 1571−1588.
- Hudson, L.G. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression / L.G. Hudson, R. Zeineldin, M.S. Stack // Clin. Exp. Metastasis. 2008. — Vol. 25. — № 6. — P. 643−655.
- Husband, A.J. The immune system and integrated homeostasis / A.J. Husband // Immunol. Cell Biol. 1995. — Vol. 73. — № 4. — P. 377−382.
- Ioannides, C.G. Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene / C.G. Ioannides, B. Fisk, D. Fan et al. // Cell. Immunol. 1993. — Vol. 151. — № 1. — P.225.234.
- Ishikawa, F. New biodefense strategies by neutrophils / F. Ishikawa, S. Miyazaki // Arch. Immunol. Ther. Exp. (Warsz). 2005. — Vol. 53. — № 3. — P.226.233.
- Ito, M. Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node / M. Ito, Y. Minamiya, H. Kawai et al. // J. Immunol. -2006.-Vol. 176.-№ 9.-P. 5637−5643.
- Ito, S. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients / S. Ito, H. Nakanishi, Y. Kodera et al. // Br. J. Cancer.-2005.-Vol. 93.-№ 9.-P. 986−992.
- Jain, S. Prostaglandin E2 regulates tumor angiogenesis in prostate cancer / S. Jain, G. Chakraborty, R. Raja et al. // Cancer Res. 2008. — Vol. 68. -№ 19.-P. 7750−7759.
- Jiang, H. How the immune system achieves self-nonself discrimination during adaptive immunity / H. Jiang, L. Chess // Adv. Immunol. 2009. — Vol. 102.-P. 95−133.
- Jung, M.Y. Analysis of the expression profiles of cytokines and cytokine-related genes during the progression of breast cancer growth in mice / M.Y. Jung, S.H. Kim, D. Cho, T.S. Kim // Oncol. Rep. 2009. — Vol. 22. — № 5. -P. 1141−1147.
- Kang, J.S. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44 /J.S. Kang, S.Y. Bae, H.R. Kim et al. // Carcinogenesis. 2009. — Vol. 30. — № 12. — P. 1987−1996.
- Kawaida, H. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer / H. Kawaida, K. Kono, A. Takahashi et al.//J. Surg. Res.-2005.-Vol. 124.-№ 1.-P. 151−157.
- Kawakami, Y. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor / Y. Kawakami, S. Eliyahu, C.H. Delgado et al. // Proc. Natl. Acad. Sci. USA.- 1994. -Vol. 91.-№ 9.-P. 3515−3519.
- Kawashima, M. Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis / M. Kawashima, D. Novick, M. Rubinstein, P. Miossec // Arthritis Rheum. 2004. -Vol. 50. -№ 6. — P. 1800−1805.
- Kim, D.K. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer / D.K. Kim, S.Y. Oh, H.C. Kwon et al. // BMC Cancer. 2009. — Vol. 9. — P. 155.
- Kim, J. IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway / J. Kim, C. Kim, T.S. Kim et al. // Biochem. Biophys. Res. Commun. 2006. — Vol. 344. — № 4. — P. 1284−1289.
- Kim, K.E. Interleukin-18 is a critical factor for vascular endothelial growth factor-enhanced migration in human gastric cancer cell lines / K.E. Kim, H. Song, T.S. Kim etal.//Oncogene.-2007.-Vol. 26.-№ 10.-P. 1468−1476.
- Kim, R. Cancer cell immune escape and tumor progression by exploitation of anti-inflammatory and pro-inflammatory responses / R. Kim, M. Emi, K. Tanabe // Cancer Biol. Ther. 2005. — Vol. 4. — № 9. — P. 924−933.
- Kim, R. Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity / R. Kim, M. Emi, K. Tanabe // Clin. Exp. Immunol. 2006. — Vol. 146. — № 2. — P. 189−196.
- Kim, R. Tumor-driven evolution of immunosuppressive networks during malignant progression / R. Kim, M. Emi, K. Tanabe, K. Arihiro // Cancer Res. 2006. — Vol. 66. — № 11. — P. 5527−5536.
- Kim, R. Cancer immunoediting from immune surveillance to immune escape / R. Kim, M. Emi, K. Tanabe // Immunology. 2007. — Vol. 121. — № 1. -P. 1−14.
- Kioi, M. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy / M. Kioi, S. Takahashi, M. Kawakami et al. //Cancer Res. 2005. — Vol. 65. -№ 18.-P. 8388−8396.
- Kornek, G. Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours / G. Kornek, T. Schenk, M. Raderer et al. // Br. J. Cancer. 1995. — Vol. 71. — № 1. — P. 182 185.
- Kulbe, H. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells / H. Kulbe, R. Thompson, J.L. Wilson et al. // Cancer Res. 2007. — Vol. 67. — № 2. -P. 585−592.
- Kumar, S. Mechanics, malignancy, and metastasis: the force journey of a tumor cell / S. Kumar, V.M. Weaver // Cancer Metastasis Rev. 2009. — Vol. 28. -№ 1−2.-P. 113−127.
- Kusmartsev, S. Role of immature myeloid cells in mechanisms of immune evasion in cancer / S. Kusmartsev, D.I. Gabrilovich // Cancer Immunol. Immunother. 2006. — Vol. 55. — № 3. — P. 237−245.
- Kuusela, P. Comparison of a new tumour marker CA 242 with CA 199, CA 50 and carcinoembryonic antigen (СБА) in digestive tract diseases / P. Kuusela, C. Haglund, P.J. Roberts // Br. J. Cancer. 1991. — Vol. 63. — № 4. — P. 636−640.
- Kuwano, K. Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family / K. Kuwano, N. Hara // Am. J. Respir. Cell Mol. Biol. 2000. — Vol. 22. — № 2. — P. 147−149.
- Kyewski, B. A central role for central tolerance / B. Kyewski, L. Klein // Annu Rev. Immunol. 2006. — Vol. 24. — P. 571−606.
- Lamagna, C. Dual role of macrophages in tumor growth and angiogenesis / C. Lamagna, M. Aurrand-Lions, B.A. Imhof // J. Leukoc. Biol. -2006.-Vol. 80.-№ 4.-P. 705−713.
- Last’ovicka, J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers / J. Last’ovicka, V. Budinsky, R. Spisek, J. Bartunkova // Cell. Immunol. 2009. — Vol. 256. — № 1−2. -P. 79−85.
- Le, N.H. Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer sternness / N.H. Le, P. Franken, R. Fodde // Br. J. Cancer.-2008.-Vol. 98.-№ 12.-P. 1886−1893.
- Leach, S.T. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease / S.T. Leach, I. Messina, D.A. Lemberg et al. // Inflamm. Bowel Dis. 2008. — Vol. 14. — № 1. -P. 68−74.
- Lehner, T. Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation / T. Lehner // Immunology. -2008. Vol. 123. — № 1. — P. 40−44.
- Lewis, A.M. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment / A.M. Lewis, S. Varghese, H. Xu, H.R. Alexander // J. Transl. Med. 2006. -Vol. 4.-P. 48.
- Li, A. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis / A. Li, S. Dubey, M.L. Varney et al. // J. Immunol. 2003. — Vol. 170. — № 6. — P. 33 693 376.
- Li, B. Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells how diverse signals regulate suppression / B. Li, M.I. Greene // Immunology. — 2008. — Vol. 123. -№ l.-P. 17−19.
- Li, G. A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model / G. Li, S. Andreansky, G. Helguera et al. // Mol. Cancer Ther. 2008. — Vol. 7. — № 3. — P. 721−729.
- Lima, L.G. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner / L.G. Lima, R. Chammas, R.Q. Monteiro et al. // Cancer Lett. 2009. — Vol. 283. — № 2. — P. 168 175.
- Lin, M.T. IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1 / M.T. Lin, C.Y. Juan, K.J. Chang et al. // Carcinogenesis. 2001. — Vol. 22. -№ 12.-P. 1947−1953.
- Ling, K.L. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients / K.L. Ling, S.E. Pratap, G.J. Bates et al. // Cancer Immun. 2007. — Vol. 7. — P. 7.
- Loddenkemper, С. In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer / C. Loddenkemper, M. Schernus, M. Noutsias et al. // J. Transl. Med. 2006. — Vol. 4. — P. 52.
- Lotfi, R. Immunotherapy for cancer: promoting innate immunity / R. Lotfi, H. Schrezenmeier, M.T. Lotze // Front. Biosci. 2009. — Vol. 14. — P. 818 832.
- Loussouarn, D. Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas / D. Loussouarn, L. Campion, C. Sagan et al. // Br. J. Cancer. 2008. — Vol. 98. — № 12. — P. 1993−1998.
- Lu, B. T-cell death and cancer immune tolerance / B. Lu, O.J. Finn // Cell Death Differ. 2008. — Vol. 15. — № 1. — P. 70−79.
- Lukacher, A.E. IFN-gamma suspends the killing license of anti-tumor CTLs / A.E. Lukacher // J. Clin. Invest. 2002. — Vol. 110. — № 10. — P. 14 071 409.
- Lukaszewicz, M. Clinical significance of interleukin-6 (IL-6) as a prognostic factor of cancer disease / M. Lukaszewicz, B. Mroczko, M. Szmitkowski // Pol. Arch. Med. Wewn. 2007. — Vol. 117. — № 5−6. — P. 247−251.
- Lundgren, A. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients / A. Lundgren, E. Stromberg, A. Sjoling et al. // Infect. Immun. 2005. — Vol. 73. — № 1. — P. 523−531.
- Lundin, M. Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression / M. Lundin, S. Nordling, J. Lundin et al. // Int. J. Cancer. 2001. — Vol. 95. — № 1. -P. 18−22.
- Luo, D. Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis / D. Luo, Y. Luo, Y. He et al. // Am. J. Pathol. 2006. — Vol. 169. -№ 5. — P. 1886−1898.
- Ma, J. Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-l/NF-kappaB synergy / J. Ma, Z. Ren, Y. Ma et al. // J. Biol. Chem. 2009. — Vol. 284. -№ 50.-P. 34 600−34 606.
- Ma, Y.M. A pilot study on acute inflammation and cancer: a new balance between IFN-gamma and TGF-beta in melanoma / Y.M. Ma, T. Sun, Y.X. Liu et al. // J. Exp. Clin. Cancer Res. 2009. — Vol. 28. — P. 23.
- Malavasi, F. CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity / F. Malavasi, S. Deaglio, E. Ferrero et al. // Mol. Med. 2006. — Vol. 12. — № 11−12. — P. 334−341.
- Mallat, Z. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb / Z. Mallat, J.S. Silvestre, S. Le Ricousse-Roussanne et al. // Circ. Res. 2002. — Vol. 91. — № 5. -P. 441−448.
- Mantovani, A. The yin-yang of tumor-associated neutrophils / A. Mantovani // Cancer Cell. 2009. — Vol. 16. — № 3. — P. 173−174.
- Mapara, M.Y. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance / M.Y. Mapara, M. Sykes // J. Clin. Oncol. -2004.-Vol. 22. -№ 6. P. 1136−1151.
- Marth, C. Characterization of an interferon-resistant mutant of the human breast cancer cell line BT-20 / C. Marth, G. Gastl, J. Zech et al. // J. Interferon Res. 1987. — Vol. 7. — № 2. — P. 195−202.
- Mayo, L. Dual role of CD38 in microglial activation and activation-induced cell death / L. Mayo, J. Jacob-Hirsch, N. Amariglio et al. // J. Immunol. -2008.-Vol. 181.-№ l.-P. 92−103.
- Mays, L.E. Maintaining immunological tolerance with Foxp3 / L.E. Mays, Y.H. Chen//Cell Res.-2007.-Vol. 17.-№ 11.-P. 904−918.
- Mazodier, К. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome / K. Mazodier, V. Marin, D. Novick et al. // Blood. 2005. — Vol. 106. — № 10. — P. 3483−3489.
- McClintock, J.Y. Role of IL-6 in systemic angiogenesis of the lung / J.Y. McClintock, E.M. Wagner // J. Appl. Physiol. 2005. — Vol. 99. — № 3. — P. 861−866.
- McKenna, R.M. Antibodies to interferon-alpha in treated cancer patients: incidence and significance / R.M. McKenna, K.E. Oberg // J. Interferon Cytokine Res.- 1997.-Vol. 17.-№ 3.-P. 141−143.
- McMahan, R.H. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines / R.H. McMahan, J.A. McWilliams, K.R. Jordan et al. // J. Clin. Invest. 2006. — Vol. 116. — № 9. — P. 2543−2551.
- McMahan, R.H. Mobilizing the low-avidity T cell repertoire to kill tumors / R.H. McMahan, J.E. Slansky // Semin. Cancer Biol. 2007. — Vol. 17. -№ 4.-P. 317−329.
- Merlo, L.M. Cancer as an evolutionary and ecological process / L.M. Merlo, J.W. Pepper, B.J. Reid, C.C. Maley // Nat. Rev. Cancer. 2006. — Vol. 6. -№ 12.-P. 924−935.
- Mitsiades, C.S. The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer / C.S. Mitsiades, V. Poulaki, N. Mitsiades // J. Endocrinol. 2003. — Vol. 178. — № 2. — P. 205−216.
- Mizukami, Y. Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer / Y. Mizukami, K. Kono, Y. Kawaguchi et al. // Br. J. Cancer. 2008. — Vol. 98. — № 1. — P. 148−153.
- Mocellin, S. Interleukin-10 and the immune response against cancer: a counterpoint / S. Mocellin, F.M. Marincola, H.A. Young // J. Leukoc. Biol. 2005. -Vol. 78.- № 5. -P. 1043−1051.
- Moll, H.P. Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells / H.P. Moll, H. Freudenthaler, A. Zommer et al. // J. Immunol. 2008. — Vol. 180. — № 8. — P. 5250−5256.
- Mosser, D.M. Interleukin-10: new perspectives on an old cytokine /
- D.M. Mosser, X. Zhang // Immunol. Rev. 2008. — Vol. 226. — P. 205−218.
- Murray, M.J. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis / M.J. Murray, B.A. Lessey // Semin. Reprod. Endocrinol. 1999. — Vol. 17. — № 3. — P. 275−290.
- Nagaraj, S. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer / S. Nagaraj, K. Gupta, V. Pisarev et al. // Nat. Med. -2007. Vol. 13. — № 7. — P. 828−835.
- Nagorsen, D. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival / D. Nagorsen, S. Voigt,
- E. Berg et al. // J. Transl. Med. 2007. — Vol. 5. — P. 62.
- Nakao, S. Infiltration of СОХ-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth / S. Nakao, T. Kuwano, C. Tsutsumi-Miyahara et al. // J. Clin. Invest. 2005. — Vol. 5. 115.-№ 11.-P. 2979−2991.
- Nam, J.S. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17 /J.S. Nam, M. Terabe, M.J. Kang et al. // Cancer Res. 2008. — Vol. 68. -№ 10. — P. 3915−3923.
- Novick, D. Interleukin-18 binding protein in the sera of patients with Wegener’s granulomatosis / D. Novick, D. Elbirt, C.A. Dinarello et al. // J. Clin. Immunol.-2009.-Vol. 29.-№ l.-P. 38−45.
- Numasaki, M. Interleukin-17 promotes angiogenesis and tumor growth / M. Numasaki, J. Fukushi, M. Ono et al. // Blood. 2003. — Vol. 101. — № 7. — P. 2620−2627. 1
- Ohtani, H. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer / H. Ohtani // Cancer Immun. 2007. -Vol. 7.-P. 4.
- Olejniczak, K. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases a review / K. Olejniczak, A. Kasprzak // Med. Sci. Monit.-2008.-Vol. 14.-№ 10.-P. RA179-RA189.
- Osada, T. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients / T. Osada, G. Chong, R. Tansik et al. // Cancer Immunol. Immunother. 2008. — Vol. 57. — № 8. — P. 1115−1124.
- Ostrand-Rosenberg, S. Immune surveillance: a balance between pro-and anti-tumor immunity / S. Ostrand-Rosenberg // Curr. Opin. Genet. Dev. -2008. Vol. 18. — № 1. — P. 11−18.
- Ostrand-Rosenberg, S. Myeloid-derived suppressor cells: linking inflammation and cancer / S. Ostrand-Rosenberg, P. Sinha // J. Immunol. 2009. -Vol. 182. — № 8. — P. 4499−4506.
- Paez-Ribes, M. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis / M. Paez-Ribes, E. Allen, J. Hudock et al. // Cancer Cell. 2009. — Vol. 15. — № 3. — P. 220−231.
- Palucka, A.K. Dendritic cells: a critical player in cancer therapy? / A.K. Palucka, H. Ueno, J. Fay, J. Banchereau // J. Immunother. 2008. — Vol. 31. — № 9. — P. 793−805.
- Pan, P.Y. Advancements in immune tolerance / P.Y. Pan, J. Ozao, Z. Zhou, S.H. Chen // Adv. Drug Deliv. Rev. 2008. — Vol. 60. — № 2. — P. 91−105.
- Pan, S. Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis / S. Pan, P. An, R. Zhang et al. // Mol. Cell. Biol. 2002. — Vol. 22. — № 21. — P. 7512−7523.
- Persano, L. Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer / L. Persano, L. Moserle, G. Esposito et al. // Carcinogenesis. 2009. — Vol. 30. — № 5. -P. 851−860.
- Pettit, S.J. Immune selection in neoplasia: towards a microevolutionary model of cancer development / S.J. Pettit, K. Seymour, E. O’Flaherty, J.A. Kirby // Br. J. Cancer. 2000. — Vol. 82.-№ 12.-P. 1900−1906.
- Phelan, J.D. Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies / J.D. Phelan, T. Orekov, F.D. Finkelman // J. Immunol. 2008. — Vol. 180. — № 1. — P. 44−48.
- Pollard, J.W. Macrophages define the invasive microenvironment in breast cancer / J.W. Pollard // J. Leukoc. Biol. 2008. — Vol. 84. — № 3. — P. 623 630.
- Prokopchuk, O. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions / O. Prokopchuk, Y. Liu, D. Henne-Bruns, M. Kornmann // Br. J. Cancer. 2005. -Vol. 92. -№ 5. — P. 921−928.
- Pugliese, A. Central and peripheral autoantigen presentation in immune tolerance / A. Pugliese // Immunology. 2004. — Vol. 111. — № 2. — P. 138−146.
- Quante, M. Inflammation and stem cells in gastrointestinal carcinogenesis / M. Quante, T.C. Wang // Physiology (Bethesda). 2008. — Vol. 23.-P. 350−359.
- Raman, D. Role of chemokines in tumor growth / D. Raman, P.J. Baugher, Y.M. Thu, A. Richmond // Cancer Lett. 2007. — Vol. 256. — № 2. — P. 137−165.
- Reiman, J.M. Tumor immunoediting and immunosculpting pathways to cancer progression / J.M. Reiman, M. Kmieciak, M.H. Manjili, K.L. Knutson // Semin. Cancer Biol. 2007. — Vol. 17. — № 4. — P. 275−287.
- Revoltella, R.P. Natural and therapeutically-induced antibodies to cytokines / R.P. Revoltella // Biotherapy. 1998. — Vol. 10. — № 4. — P. 321−331.
- Ribatti, D. The role of microenvironment in tumor angiogenesis / D. Ribatti, A. Vacca // Genes. Nutr. 2008. — Vol. 3. — № 1. — p. 29−34.
- Richter, G.H. CD25 blockade protects T cells from activation-induced cell death (AICD) via maintenance of TOSO expression / G.H. Richter, A. Mollweide, K. Hanewinkel et al. // Scand. J. Immunol. 2009. — Vol. 70. — № 3. -P. 206−215.
- Ridolfi, L. Human embryo immune escape mechanisms rediscovered by the tumor / L. Ridolfi, M. Petrini, L. Fiammenghi et al. // Immunobiology. -2009.-Vol. 214.-№ l.-P. 61−76.
- Rivoltini, L. Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity / L. Rivoltini, D.J. Loftus, P. Squarcina et al. // Crit. Rev. Immunol. 1998. — Vol. 18. -№ 1−2.-P. 55−63.
- Rose-John, S. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer / S. Rose-John, J. Scheller, G. Elson, S.A. Jones // J. Leukoc. Biol. 2006. — Vol. 80. — № 2. -P.227−236.
- Ross, С. High avidity IFN-neutralizing antibodies in pharmaceutical^ prepared human IgG / C. Ross, M. Svenson, M.B. Hansen et al. // J. Clin. Invest. -1995.-Vol. 95.-№ 5.-P. 1974−1978.
- Rubie, C. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer / C. Rubie, V.O. Frick, S. Pfeil et al. // World J. Gastroenterol. 2007. — Vol. 13. — № 37. — P. 4996−5002.
- Ruddy, M.J. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members / M.J. Ruddy, G.C. Wong, X.K. Liu et al. // J. Biol. Chem. 2004. — Vol. 279,-№ 4.-P. 2559−2567.
- Sawada, K. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target / K. Sawada, A.K. Mitra, A.R. Radjabi et al. // Cancer Res. 2008. — Vol. 68. — № 7. — P. 2329−2339.
- Scharenberg, J.G. The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2 / J.G. Scharenberg,
- A.G. Stam, B.M. von Blomberg et al. // Eur. J. Cancer. 1994. — Vol. 30A. — № 12.-P. 1804−1809.
- Schmielau, J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients / J. Schmielau, O.J. Finn // Cancer Res. 2001. — Vol. 61. -№ 12. — P. 4756−4760.
- Schwandner, R. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction / R. Schwandner, K. Yamaguchi, Z. Cao // J. Exp. Med. 2000. — Vol. 191. — № 7. — P. 1233−1240.
- Seliger, B. Strategies of tumor immune evasion / B. Seliger // BioDrugs. 2005. — Vol. 19. — № 6. — P. 347−354.
- Sethi, G. TNF: a master switch for inflammation to cancer / G. Sethi,
- B. Sung, B.B. Aggarwal //Front. Biosci. 2008. — Vol. 13. — P. 5094−5107.
- Shabtai, M. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes / M. Shabtai, H. Ye, Z. Frischer et al. // J. Urol. 2002. — Vol. 168. — № 5. — P. 2216−2219.
- Shafer-Weaver, К. T cell tolerance to tumors and cancer immunotherapy / K. Shafer-Weaver, M. Anderson, A. Malyguine, A.A. Hurwitz // Adv. Exp. Med. Biol. 2007. — Vol. 601. — P. 357−368.
- Shan, N.N. High-dose dexamethasone regulates interleukin-18 and interleukin-18 binding protein in idiopathic thrombocytopenic purpura / N.N. Shan, X.J. Zhu, Q. Wang et al. // Haematologica. 2009. — Vol. 94. — № 11. — P. 1603−1607.
- Shao, X.T. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis / X.T. Shao, L. Feng, L.J. Gu et al. // Clin. Exp. Med. 2009. — Vol. 9. — № 3. — P. 215−221.
- Shariat, S.F. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis / S.F. Shariat, B. Andrews, M.W. Kattan et al. // Urology. 2001. — Vol. 58. — № 6. — P. 1008−1015.
- Shida, Y. p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion / Y. Shida, T. Igawa, T. Hakariya et al. // Biochem. Biophys. Res. Commun. 2007. — Vol. 353.-№ 3.-P. 744−749.
- Shrout, J. beta (2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients / J. Shrout, M. Yousefzadeh, A. Dodd et al. // Br. J. Cancer. 2008. — Vol. 98. — № 12. — P. 19 992 005.
- Singh, R. Immunoediting sculpts tumor epitopes during immunotherapy / R. Singh, Y. Paterson // Cancer Res. 2007. — Vol. 67. — № 5. -P. 1887−1892.
- Sinha, P. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells / P. Sinha, V.K. Clements, A.M. Fulton, S. Ostrand-Rosenberg // Cancer Res. 2007. — Vol. 67. — № 9. — P. 4507−4513.
- Sioud, M. Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines? / M. Sioud // Scand. J. Immunol. 2009. — Vol. 70. — № 6.-P. 516−525.
- Sitkovsky, M.V. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia / M.V. Sitkovsky, J. Kjaergaard, D. Lukashev, A. Ohta // Clin. Cancer Res. 2008. — Vol. 14. — № 19. -P. 5947−5952.
- Solinas, G. Tumor-associated macrophages (ТАМ) as major players of the cancer-related inflammation / G. Solinas, G. Germano, A. Mantovani, P. Allavena // J. Leukoc. Biol. 2009. — Vol. 86. — № 5. — P. 1065−1073.
- Song, E. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer / E. Song, J. Chen, N. Ouyang et al. // Br. J. Cancer. 2001. — Vol. 85. — № 7.-P. 1047−1054.
- Soundararajan, R. Trophoblast 'pseudo-tumorigenesis': significance and contributory factors / R. Soundararajan, A.J. Rao // Reprod. Biol. Endocrinol. -2004.-Vol. 2.-P. 15.
- Sprent, J. The thymus and central tolerance. / J. Sprent, H. Kishimoto // Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2001. — Vol. 356. — № 1409. — P. 609−616.
- Srikrishna, G. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer / G. Srikrishna, H.H. Freeze // Neoplasia. 2009. — Vol. 11. — № 7. — P. 615−628.
- Starska, K. Expression of activation antigens on the lymphocytes T in patients with carcinoma of the larynx and connection with tumor features / K. Starska, E. Glowacka, M. Lukomski et al. // Otolaryngol. Pol. 2008. — Vol. 62. -№ 6. -P. 674−679.
- Stern-Ginossar, N. Intercellular transfer of carcinoembryonic antigen from tumor cells to NK cells / N. Stern-Ginossar, S. Nedvetzki, G. Markel et al. // J. Immunol. 2007. — Vol. 179. — № 7. — P. 4424−4434.
- Streicher, K.L. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells / K.L. Streicher, N.E. Willmarth, J. Garcia et al. // Mol. Cancer Res. 2007. — Vol. 5. -№ 8.-P. 847−861.
- Sun, Z. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression / Z. Sun, P. Yang // Lancet Oncol. 2004. — Vol. 5. — № 3. — P. 182−190.
- Suzuki, S. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer / S. Suzuki, K. Sasajima, Y. Sato et al. // Br. J. Cancer. 2008. — Vol. 99. — № 2. — P. 350−356.
- Svenson, M. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations / M. Svenson, M.B. Hansen, C. Ross et al. // Blood. 1998. — Vol. 91. — № 6. — P. 2054−2061.
- Szczesny, T.J. Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery / T.J. Szczesny, R. Slotwinski, A. Stankiewicz et al. // Eur. J. Cardiothorac. Surg. 2007. — Vol. 31. -№ 4.-P. 719−724.
- Takehara, H. Involvement of cyclooxygenase-2 — prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells / H. Takehara, J. Iwamoto, Y. Mizokami et al. //Dig. Dis. Sci. -2006. Vol. 51. -№ 12. — P. 21 882 197.
- Tan, A.R. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? / A.R. Tan, G. Alexe, M. Reiss // Breast Cancer Res. Treat. 2009. — Vol. 115. — № 3. — P. 453−495.
- Tan, E.M. Autoantibodies to tumor-associated antigens: reporters from the immune system / E.M. Tan, J. Zhang // Immunol. Rev. 2008. — Vol. 222. — P. 328−340.
- To, K.F. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line / K.F. To, M.W. Chan, W.K. Leung et al. // Br. J. Cancer. 2004. — Vol. 91. — № 7. -P. 1335−1341.
- Todaro, M. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells / M. Todaro, M. Zerilli, L. Ricci-Vitiani et al. // Cancer Res. 2006. — Vol. 66. — № 3. — P. 1491−1499.
- Todaro, M. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4 / M. Todaro, M.P. Alea, A.B. Di Stefano et al. // Cell Stem. Cell. 2007. — Vol. 1. — № 4. — P. 389−402.
- Toge, H. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages / H. Toge, T. Inagaki, Y. Kojimoto et al. // Int. J. Urol. -2009.-Vol. 16. -№ 10. P. 801−807.
- Torgerson, T.R. FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression / T.R. Torgerson, A. Genin, C. Chen et al. // J. Immunol. 2009. — Vol. 183. — № 2. — P. 907−915.
- Ucar, E. Prognostic value of preoperative CEA, CA 19−9, CA 72−4, and AFP levels in gastric cancer / E. Ucar, E. Semerci, H. Ustun et al. // Adv. Ther. -2008.-Vol. 25.-№ 10.-P. 1075−1084.
- Van Parijs, L. Homeostasis and self-tolerance in the immune system: turning lymphocytes off / L. Van Parijs, A.K. Abbas // Science. 1998. — Vol. 280.-№ 5361.-P. 243−248.
- Vercoulen, Y. Human Regulatory T Cell Suppressive Function Is Independent of Apoptosis Induction in Activated Effector T Cells / Y. Vercoulen, E.J. Wehrens, N.H. van Teijlingen et al. // PLoS ONE. 2009. — Vol. 4. — № 9. -P. 7183.
- Vetter, C.S. Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma / C.S. Vetter, W. Lieb, E.B. Brocker, J.C. Becker//Br. J. Cancer. 2004. — Vol. 91.-№ 8.-P. 1495−1499.
- Vulcano, M. Tolerance in intestinal inflammation and cancer / M. Vulcano, S. Danese, A. Sica // Curr. Drug. Targets. 2008. — Vol. 9. — № 5. — P. 404−412.
- Waldhauer, I. Tumor-associated MICA is shed by ADAM proteases / I. Waldhauer, D. Goehlsdorf, F. Gieseke et al. // Cancer Res. 2008. — Vol. 68. -№ 15.-P. 6368−6376.
- Wang, K.X. Helicobacter pylori L-form and patients with chronic gastritis / K.X. Wang, L. Chen // World J. Gastroenterol. 2004. — Vol. 10. — № 9. -P. 1306−1309.
- Wang, Q. Analysis of CD137 and CD137L expression in human primary tumor tissues / Q. Wang, P. Zhang, Q. Zhang et al. // Croat. Med. J. -2008. Vol. 49. — № 2. — P. 192−200.
- Watanabe, M. Anti-cytokine autoantibodies are ubiquitous in healthy individuals / M. Watanabe, K. Uchida, K. Nakagaki et al. // FEBS Lett. 2007. -Vol. 581.-№ 10.-P. 2017−2021.
- Waterston, A.M. TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model / A.M. Waterston, F. Salway, E. Andreakos et al. // Br. J. Cancer. 2004. — Vol. 90. — № 6. — P. 1279−1284.
- Waubant, E. Spotlight on anti-CD20 / E. Waubant // Int. MS J. 2008. -Vol. 15.-№ l.-P. 19−25.
- Waugh, D.J. The interleukin-8 pathway in cancer / D.J. Waugh, C. Wilson//Clin. Cancer Res. 2008. — Vol. 14. -№ 21. -P. 6735−6741.
- Wilczynski, J.R. The characterization and role of regulatory T cells in immune reactions / J.R. Wilczynski, M. Radwan, J. Kalinka // Front. Biosci. -2008. Vol. 13. — P. 2266−2274.
- Williams, L.M. Interleukin-10 suppression of myeloid cell activation -a continuing puzzle / L.M. Williams, G. Ricchetti, U. Sarma et al. // Immunology. 2004. — Vol. 113. — № 3. — P. 281−292.
- Witkowska, A.M. On the role of sIL-2R measurements in rheumatoid arthritis and cancers / A.M. Witkowska // Mediators Inflamm. 2005. — Vol. 2005. -№ 3. — P. 121−130.
- Woith, W. A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro / W. Woith, I. Nusslein, C. Antoni et al. // Clin. Exp. Immunol. 1993. — Vol. 92. -№ 3. p. 537−542.
- Xu, T. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells / T. Xu, B.C. Sun, Q. Li, X.S. Hao // World J. Gastroenterol. 2005. — Vol. 11. — № 25. — P. 3915−3919.
- Yamao, T. Tumor markers CEA, CA19−9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer / T. Yamao, S. Kai, A. Kazami et al. // Jpn. J. Clin. Oncol. 1999. — Vol. 29. — № 11. -P. 550−555.
- Yan, L. Therapeutic potential of cytokine and chemokine antagonists in cancer therapy / L. Yan, G.M. Anderson, M. DeWitte, M.T. Nakada // Eur. J. Cancer. 2006. — Vol. 42. — № 6. — P. 793−802.
- Yokokawa, J. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer / J. Yokokawa, V. Cereda, C. Remondo et al. // Clin. Cancer Res. 2008. — Vol. 14. -№ 4.-P. 1032−1040.
- You, Z. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer / Z. You, X.B. Shi, G. DuRaine et al. // Cancer Res. 2006. — Vol. 66. — № 1. — P. 175−183.
- Zhang, D. Association of IL-lbeta gene polymorphism with cachexia from locally advanced gastric cancer / D. Zhang, H. Zheng, Y. Zhou et al. // BMC Cancer. 2007. — Vol. 7. — P. 45.
- Zhou, L. The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cells / L. Zhou, H. Wang, X. Zhong et al. // Genome Biol. 2008. — Vol. 9. — № 7. — P. R119.
- Zhu, W. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats / W. Zhu, E. Mix, I. Nennesmo et al. // Exp. Neurol. 2004. — Vol. 190. — № 2. — P. 486−494.
- Ziolkowska, M. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism / M. Ziolkowska, А. Кос, G. Luszczykiewicz et al. // J. Immunol. 2000. — Vol. 164.-№ 5.-P. 2832−2838.
- Zivkovic, M. Oxidative burst and anticancer activities of rat neutrophils / M. Zivkovic, M. Poljak-Blazi, G. Egger et al. // Biofactors. 2005. -Vol. 24. -№ 1−4.-P. 305−312.
- Zwirner, N.W. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system / N.W. Zwirner, M.B. Fuertes, M.V. Girart et al. // Cytokine Growth Factor Rev. 2007. — Vol. 18. — № 1−2. — P. 159−170.